跳至主要内容
临床试验/NCT06193837
NCT06193837尚未招募不适用

Prophylactic Antibiotic in Non-complicated Low Risk Laparoscopic Cholecystectomy; Is it Worthy? A Prospective Randomized Comparative Study.

Assiut University0 个研究点目标入组 200 人开始时间: 2024年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
200
主要终点
To compare between infection rate at both groups

研究概览

简要总结

To Compare between outcomes of Antibiotic Prophylaxis and No antibiotic prophylaxis in non-complicated low risk laparoscopic cholecystectomy

详细描述

There is no doubt that Laparoscopic cholecystectomy (LC) is the surgery of choice in cholelithiasis [1].

Routine antibiotic prophylaxis in LC decreases the rate of intra and post operative infections specifically the Surgical site infection (SSI) [2]. However, the rate of antibiotic side effects remains considerable, mainly antibiotic resistance to the commonly used antibiotics as Cefoperazone and other antibiotics used in routine prophylaxis [3]. So Some studies proved that No need for antibiotic prophylaxis [4]. In spite, no antibiotic prophylaxis may lead to infections mainly SSI and prolongation of hospitalization time [5]. However None of these studies has proved Superiority over the other and stills a matter of controversy [6]. For this reason more efforts are directed to limit the use of antibiotic in non complicated low risk laparoscopic cholecystectomy. Prophylaxis in this study is directed to start from time of admission till 1 month post operative. In our study we Follow both outcomes to compare between both techniques

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult male and female at the Age of 18 years or above.
  • Symptomatic gall bladder stones.
  • Ultrasonography shows gall bladder stones.
  • Uncomplicated chronic calculous cholecystitis

排除标准

  • Complicated gall bladder stones.
  • Malignant gall bladder mass
  • Laparoscopic cholecystectomy with Common Bile Duct (CBD) exploration.
  • Absolute contraindications to LC like cardiovascular, pulmonary disease, coagulopathies and end stage liver disease.
  • The cases of Laparoscopic Cholecystectomy conversion to Open Cholecystectomy due to equipment failure.
  • Immunocompromised patients as Uncontrolled DM, HIV and patients on certain medications as corticosteroids and chemotherapy.

研究组 & 干预措施

Group 1

Having prophylactic antibiotic in laparoscopic cholecystectomy

干预措施: Augmentin (Drug)

结局指标

主要结局

To compare between infection rate at both groups

时间窗: Baseline

Group 1; Prophylactic Antibiotics in LC and Group 2; No prophylactic antibiotics in LC

Hospitalization time

时间窗: Baseline

Group 1; Prophylactic Antibiotics in LC and Group 2; No prophylactic antibiotics in LC

次要结局

  • Improve quality of life to reduce mortality and morbidity in patients with chronic cholecystitis(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Hassan Mohammed Ali

Assiut Lecturer

Assiut University

相似试验